Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Getty Realty Corp. (Symbol: GTY), where a total of 1,544 contracts have traded so far, representing approximately 154,400 underlying shares. That amounts to about 119% of GTY's average daily trading volume over the past month of 129,735 shares. Particularly high volume was seen for the $17.50 strike call option expiring March 18, 2016 , with 1,500 contracts trading so far today, representing approximately 150,000 underlying shares of GTY. Below is a chart showing GTY's trailing twelve month trading history, with the $17.50 strike highlighted in orange:

BioMarin Pharmaceutical Inc. (Symbol: BMRN) saw options trading volume of 9,871 contracts, representing approximately 987,100 underlying shares or approximately 72.4% of BMRN's average daily trading volume over the past month, of 1.4 million shares. Especially high volume was seen for the $100 strike put option expiring November 20, 2015 , with 3,162 contracts trading so far today, representing approximately 316,200 underlying shares of BMRN. Below is a chart showing BMRN's trailing twelve month trading history, with the $100 strike highlighted in orange:

And InvenSense, Inc. (Symbol: INVN) saw options trading volume of 11,443 contracts, representing approximately 1.1 million underlying shares or approximately 62.5% of INVN's average daily trading volume over the past month, of 1.8 million shares. Particularly high volume was seen for the $12 strike put option expiring December 18, 2015 , with 5,625 contracts trading so far today, representing approximately 562,500 underlying shares of INVN. Below is a chart showing INVN's trailing twelve month trading history, with the $12 strike highlighted in orange:

For the various different available expirations for GTY options , BMRN options , or INVN options , visit StockOptionsChannel.com.
Today's Most Active Call & Put Options of the S&P 500 »
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.